GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
4 hedge funds and large institutions have $916K invested in VanEck Vectors Generic Drugs ETF in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NFG
Next Financial Group
Houston,
Texas
|
+$7K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$25.4K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $848K | -$25.4K | -1,050 | -3% |
|
|
IA
2
IFP Advisors
Tampa,
Florida
| $55K | – | – | – |
|
|
NFG
3
Next Financial Group
Houston,
Texas
| $7K | +$7K | +300 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $6K | – | – | – |
|